Wormwood in Chronic Progressive Disorders With Reduced Appetite

University Hospital Freiburg300 enrolled

Overview

Wormwood is approved herbal medicine for the treatment of reduced appetite in Germany (Registration No.: 1339.99.99). Reduced appetite is observed in many chronic health disorders such as old age, immune disorders and cancer. Trial aims at observing beneficial effects of wormwood supplementation in various chronic disorders associated with reduced appetite

Supplementation with wormwood in chronic disorders associated with reduced appetite. Examples: 1. Cancer 2. Autoimmune diseases such as Crohns disease and IgA Nephropathy 3. Old age 4. Chronic stress and depression

Study Type

OBSERVATIONAL

Enrollment

300

Conditions

Cancer

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Appetite and weight loss * Chronic progressive disease Exclusion Criteria: * Life expectancy less than 3 months

Locations (1)

University of Freiburg, Medical Faculty

Freiburg im Breisgau, Baden, Germany

RECRUITING

Outcomes

Primary Outcomes

Improvement in appetite

Time frame: 6-12 months

Secondary Outcomes

Improvement in quality of life

Time frame: 12-24 months

Central Contacts

Simone S Krebs, MD, Ph.D

CONTACT

(+49) -761-27-3913 simone.krebs@uniklinik-freiburg.de

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.